SCHEMBL8329086

SCHEMBL8329086

CN(C(=O)C1CC1)C1CC1c1cccc(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 1/20 0.44
HTR2A P28223 2/20 0.41
HTR2C P28335 2/20 0.41
HTR2B P41595 2/20 0.41
HTT P42858 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
MAOA P21397 1/20 0.40
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
GPR88 Q9GZN0 1/20 0.39
OPRK1 P41145 1/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8333596 0.85 SLC9A1 (0.47) SLC9A1HTR2AHTR2CHTR2BHTT
SCHEMBL8333635 0.84 HTR2A (0.44) SLC9A1HTR2AHTR2CHTR2BHTT
SCHEMBL8330285 0.82 HSD17B1 (0.48) SLC9A1HTR2AHTR2CHTR2BHSD17B1
SCHEMBL8332792 0.79 HTR2A (0.43) SLC9A1HTR2AHTR2CHTR2BHTT
SCHEMBL8330750 0.71 KDM1A (0.46) GPR88
SCHEMBL1223671 0.70 SLC9A1 (0.53) SLC9A1HTR2AHTR2CHTR2BGPR88
SCHEMBL1223675 0.70 SLC9A1 (0.53) SLC9A1HTR2AHTR2CHTR2BGPR88
SCHEMBL13093203 0.69 HTT (0.47) SLC9A1HTTSLC6A2SLC6A4SLC6A3
SCHEMBL8331070 0.69 HTR2C (0.44) HTR2AHTR2CHTR2BMAOAGPR88
SCHEMBL24737783 0.68 SLC9A1 (0.66) SLC9A1HTR2AHTR2CHTR2BHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5889031-A CONTROLLING CIRCADIAN RHYTHMS BRISTOL-MYERS SQUIBB COMPNAY (US) 1999-03-30 US disclosed
US-5753709-A N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics BRISTOL-MYERS SQUIBB COMPANY (US) 1998-05-19 US disclosed